BC
Bachem Holding AG
BCHMF · OTC
$91.00 +0.00% (+$0.00)
Market Cap CHF 5.65B
P/E Ratio 37.94x
Div. Yield 0.63%
ROE 10.55%
Bulios Fair Price
$62
31.9% downside
Current Price
$91
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BCHMF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
19 /100
Expensive P/E 37.94x
EV/EBITDA 29.87x
P/S 8.12x
Growth
68 /100
Growing EPS growth 13.06%
Rev. growth 9.36%
Book val. growth 7.65%
Profitability
57 /100
Moderate Gross margin 28.74%
Net margin 21.41%
Op. margin 21.62%
Quality
46 /100
Average ROIC 8.12%
ROE 10.55%
ROA 7.06%
Debt
99 /100
Low Debt/Equity 0.04x
Current ratio 1.79x
Int. coverage 310.51x
Stability
100 /100
Stable Beta 0.81x
Rev. volatility 5.08%
EPS volatility 9.16%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BCHMF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Anne-Kathrin Stoller
Employees
2,511
Headquarters
Bubendorf
Upcoming events
04 MAR
Earnings
Upcoming earnings report